Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/16/19
End: 06/10/22
Due: 06/10/23
Phase: N/A
Priority: Normal
Start: 06/02/16
End: 07/15/16
Due: 07/15/17
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban | NCT03809481 | Aspen Global Incorporated | user2@example.com | None | 2019-05-16 | 2022-06-10 | 2023-06-10 | - | - | 2025-07-14 |
| A Study Comparing the Local Tolerability of Two Subcutaneous Heparins in Healthy Volunteers. | NCT03841396 | Aspen Global Incorporated | user2@example.com | None | 2016-06-02 | 2016-07-15 | 2017-07-15 | - | - | 2025-07-14 |